跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目1026-1050 / 12927. (共518頁) << < 37 38 39 40 41 42 43 44 45 46 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-07-08	Aryl hydrocarbon receptor confers protection against macrophage pyroptosis and intestinal inflammation through regulating polyamine biosynthesis	Theranostics. 2024 Jul 08;14(11):4218-4239.
2013-04	Aryl hydrocarbon receptor controls murine mast cell homeostasis	Blood. 2013 Apr;121(16):3195-3204.
2022-09-21	Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy	Biomedicine and Pharmacotherapy. 2022 Sep 21;155:Article number 113725.
2012-05	Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer	Oncogene. 2012 May;31(20):2555-2565.
2013-03	Aryl hydrocarbon receptor is a target of 17-allylamino-17-demethoxygeldanamycin and enhances its anticancer activity in lung adenocarcinoma cells	Molecular Pharmacology. 2013 Mar;83(3):605-612.
2021-02-05	Aryl hydrocarbon receptor is essential in the control of lung club cell homeostasis	Journal of Inflammation Research. 2021 Feb 5;14:299-311.
2015-07	Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia	GLIA. 2015 Jul;63(7):1138-1154.
2021-05	Aryl hydrocarbon receptor promotes lipid droplet biogenesis and metabolic shift in respiratory Club cells	Human Cell. 2021 May;34(3):785-799.
2012-03	Aryl hydrocarbon receptor protects lung adenocarcinoma cells against cigarette sidestream smoke particulates-induced oxidative stress	Toxicology and Applied Pharmacology. 2012 Mar;259(3):293-301.
2017-01	Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma	Oncotarget. 2017 Jan;8(5):7489-7501.
2018-12-28	Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma[Erratum: Oncotarget. 2017 Jan;8(5):7489-7501.]	Oncotarget. 2018 Dec 28;9(102):37807.
2019-10	Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase	Cellular and Molecular Immunology. 2019 Oct;16(10):783-790.
2018-09	Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase[Erratum: Cellular and Molecular Immunology. 2019 Oct;16(10):783-790.]	Cellular and Molecular Immunology. 2018 Sep;15(9):870.
2012-11-15	Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice	Cancer Research. 2012 Nov 15;72(22):5790-5800.
2023-08	Aryl hydrocarbon receptor-kynurenine axis promotes oncogenic activity in BCP-ALL	Cell Biology and Toxicology. 2023 Aug;39(4):1471-1487.
2016-09-30	Aryl hydrocarbon receptor-ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism	Toxicology. 2016 Sep 30;370:116-126.
2006-10	Asbestos-related diseases from environmental exposure to crocidolite in Da-yao, China. II. An update study on mesothelloma and lung cancer mortality from a residentially exposed cohort and from local surveys and statistics	Lung Cancer. 2006 Oct;54(Suppl. 1):S11.
2005-12	Ascertaining HIV underreporting in low prevalence countries using the approximate ratio of underreporting	Journal of Biological Systems. 2005 Dec;13(4):441-454.
2016-10	Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor	Cancer Research and Treatment. 2016 Oct;48(4):1155-1166.
2019-04-11	Asian culturally specific predictors in a large-scale land use regression model to predict spatial-temporal variability of ozone concentration	International Journal of Environmental Research and Public Health. 2019 Apr 11;16(7):Article number 1300.
2008	The Asian Vaccine Industry: Opportunities and challenges	Pharma Focus Asia. 2008;6:42-46.
2023-02	ASO visual abstract: Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment	Annals of Surgical Oncology. 2023 Feb;30(2):1182-1183.
2020-03-18	Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling	Phytomedicine. 2020 Mar 18;69:Article number 153210.
2022-02	Aspalathus linearis suppresses AKT signaling, c-Myc, AR and survival of enzalutamide-resistant prostate cancer cells	Cancer Science. 2022 Feb;113(S1):1338.
2022-07-01	Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor	PLoS ONE. 2022 Jul 1;17(7):Article number e0270803.

顯示項目1026-1050 / 12927. (共518頁) << < 37 38 39 40 41 42 43 44 45 46 > >> 每頁顯示[10|25|50]項目